I would be happier if there’s a 0 after the 6 =) I think the SP will blow past $6 if the FDA agrees to end Phase 1 early due to high efficacy against ovarian, pancreatic and other solid tumors. This could happen within six months. Combine K with uplisting and a possible deal for B, oh boy!